Literature DB >> 8374633

Resuscitation, stabilization, and transport in perinatology.

A G James1.   

Abstract

Regionalization of perinatal care and the efficient provision of effective and safe interhospital transport of premature and critically ill newborn infants have evolved over two decades. Antenatal transfer of the high-risk fetus to a tertiary perinatal center is optimal but not always achievable. Neonatal transport is a complex, highly organized, dynamic process that is still evolving. Resuscitation and stabilization, supported by the tertiary perinatal care center, commence within the environment of the community hospital. Current developments improving communication with community physicians and the availability of outreach education programs assist these processes. Transport remains a sophisticated, highly technological procedure that requires extremely skilled personnel. The application of new ventilatory techniques and other strategies may enable the safer transport of critically ill newborn infants. Regionalization of perinatal care has been achieved in many areas, but its viability is threatened by the current competitive health care environment. The neonatal transport team is likely to be the most potent stimulus for the development of the "perinatal partnership" during the current decade.

Entities:  

Mesh:

Year:  1993        PMID: 8374633     DOI: 10.1097/00008480-199304000-00003

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  2 in total

1.  Improved outcomes of transported neonates in Beijing: the impact of strategic changes in perinatal and regional neonatal transport network services.

Authors:  Xiang-Yong Kong; Xiu-Xiang Liu; Xiao-Yang Hong; Jing Liu; Qiu-Ping Li; Zhi-Chun Feng
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

2.  Census of neonatal transfers in London and the South East of England.

Authors:  S T Kempley; A K Sinha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.